IS4725A - Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa - Google Patents

Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa

Info

Publication number
IS4725A
IS4725A IS4725A IS4725A IS4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A
Authority
IS
Iceland
Prior art keywords
amidine
derivatives
nitric oxide
oxide synthase
inhibit nitric
Prior art date
Application number
IS4725A
Other languages
English (en)
Inventor
Macdonald James
Matz James
Shakespeare William
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600275A external-priority patent/SE9600275D0/xx
Priority claimed from SE9603301A external-priority patent/SE9603301D0/xx
Priority claimed from SE9603300A external-priority patent/SE9603300D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4725A publication Critical patent/IS4725A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treating Waste Gases (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Gas Separation By Absorption (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IS4725A 1995-11-07 1998-04-24 Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa IS4725A (is)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US627695P 1995-11-07 1995-11-07
US625395P 1995-11-07 1995-11-07
SE9600275A SE9600275D0 (sv) 1996-01-25 1996-01-25 Compounds
SE9603301A SE9603301D0 (sv) 1996-09-11 1996-09-11 Compounds and compositions
SE9603300A SE9603300D0 (sv) 1996-09-11 1996-09-11 Compounds
PCT/SE1996/001425 WO1997017344A1 (en) 1995-11-07 1996-11-06 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Publications (1)

Publication Number Publication Date
IS4725A true IS4725A (is) 1998-04-24

Family

ID=27532790

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4725A IS4725A (is) 1995-11-07 1998-04-24 Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa

Country Status (24)

Country Link
EP (1) EP0861250B1 (is)
JP (1) JP2000500132A (is)
KR (1) KR19990067349A (is)
AT (1) ATE213241T1 (is)
AU (1) AU701329B2 (is)
BR (1) BR9611276A (is)
CA (1) CA2235301A1 (is)
CZ (1) CZ139298A3 (is)
DE (1) DE69619259T2 (is)
DK (1) DK0861250T3 (is)
EE (1) EE9800141A (is)
ES (1) ES2171743T3 (is)
HU (1) HUP9900142A3 (is)
IL (1) IL124296A0 (is)
IS (1) IS4725A (is)
NO (1) NO982072L (is)
NZ (1) NZ322227A (is)
PL (1) PL326554A1 (is)
PT (1) PT861250E (is)
SI (1) SI0861250T1 (is)
SK (1) SK61098A3 (is)
TR (1) TR199800813T2 (is)
TW (1) TW458978B (is)
WO (1) WO1997017344A1 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4947197A (en) * 1996-10-16 1998-05-11 Glaxo Group Limited Tetrahydro-6h-pyrazino{1,2-b}isoquinoline 1,4-diones as apoprotein b-100 inhibitors
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
SE9901901D0 (sv) * 1999-05-26 1999-05-26 Astra Ab Compounds
US7393652B2 (en) 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
NZ533358A (en) 2001-12-19 2007-05-31 Lundbeck & Co As H 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists
US6608193B2 (en) * 2001-12-21 2003-08-19 The Procter & Gamble Company Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
AU2003257300B2 (en) * 2002-08-07 2010-01-21 Neuraxon Inc. Amino benzothiazole compounds with NOS inhibitory activity
US7544678B2 (en) 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ１ライアノジン受容体に基づく方法
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
EP1910321A4 (en) * 2005-07-05 2010-09-01 Astrazeneca Ab NEW COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, INTERMEDIATE PRODUCTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6-MEDIATED ILLNESSES SUCH AS ALZHEIMER'S DISEASE, COGNITIVE ILLUSTRATIONS, SCHOISOPHRENIC ASSOCIATED COGNITIVE DISORDERS, OBESITAS AND PARKINSON DISEASE
EP2123644B1 (en) 2007-03-07 2014-12-17 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
JP7005629B2 (ja) 2016-12-23 2022-01-21 第一三共株式会社 Ｔｎａｐ阻害活性を有するスルホンアミド化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy
CZ29996A3 (en) * 1993-08-12 1996-09-11 Astra Ab Amidine derivatives with activities of nitrogen oxide sythetase
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
DK0861250T3 (da) 2002-04-29
HUP9900142A2 (hu) 1999-05-28
TR199800813T2 (xx) 1998-07-21
AU701329B2 (en) 1999-01-28
CA2235301A1 (en) 1997-05-15
SK61098A3 (en) 1999-01-11
KR19990067349A (ko) 1999-08-16
DE69619259T2 (de) 2002-09-19
ES2171743T3 (es) 2002-09-16
PL326554A1 (en) 1998-09-28
ATE213241T1 (de) 2002-02-15
HUP9900142A3 (en) 2001-08-28
TW458978B (en) 2001-10-11
DE69619259D1 (de) 2002-03-21
WO1997017344A1 (en) 1997-05-15
MX9803453A (es) 1998-09-30
NZ322227A (en) 1999-11-29
SI0861250T1 (en) 2002-06-30
CZ139298A3 (cs) 1998-09-16
JP2000500132A (ja) 2000-01-11
EE9800141A (et) 1998-10-15
EP0861250A1 (en) 1998-09-02
EP0861250B1 (en) 2002-02-13
IL124296A0 (en) 1998-12-06
BR9611276A (pt) 1999-01-26
NO982072L (no) 1998-07-03
PT861250E (pt) 2002-07-31
AU7592796A (en) 1997-05-29
NO982072D0 (no) 1998-05-06

Similar Documents

Publication Publication Date Title
CO5031285A1 (es) Triarilimidazoles
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO996108L (no) 9-oksinerytromycinderivater
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
SE9803518D0 (sv) Novel compounds
FI934298A0 (fi) Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK0533516T3 (da) Hidtil ukendte 1-(alkoxybenzyl)piperazinamidforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK624989A (da) Makrolidforbindelser
MXPA99009882A (es) Derivados de amidina como inhibidores de la oxidonitrico sintasa.
SE9901901D0 (sv) Compounds
SE9904676D0 (sv) Novel compounds
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
NZ501982A (en) N-oxide forms of 2,4,4-trisubstituted-1,3-dioxolane as anti-fungal agents
SE0000477D0 (sv) Novel compounds
SE9802650D0 (sv) Compounds
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater